<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

Positive Long-Term Growth Outlook for Novartis AG Amid Temporary Setbacks

PremiumRatings

2d ago

FDA moves to accelerate biosimilar development, lower drug costs

PremiumThe Fly

3d ago

AZN

BMY

PremiumThe Fly

Novartis reports NEPTUNUS-1 and NEPTUNUS-2 achieved primary objective

4d ago

Tourmaline Bio acquisition completed by Novartis

PremiumThe Fly

5d ago

TRML

PremiumThe FlyWarner Bros. Discovery upgraded, F5 downgraded: Wall Street’s top analyst calls

5d ago

Novartis announces expiration of Tourmaline Bio tender offer

The Fly

Novartis announces expiration of Tourmaline Bio tender offer

5d ago

TRML

Novartis price target raised to CHF 108 from CHF 105 at Morgan Stanley

The Fly

Novartis price target raised to CHF 108 from CHF 105 at Morgan Stanley

6d ago

Midday Fly By: Novartis to buy Avidity, Keurig Dr Pepper beats expectations

PremiumThe Fly

6d ago

PremiumThe Fly

Video: Merger Monday with deals announced in biotechnology and banking

6d ago

AWK

DYN

PremiumThe Fly

Avidity acquisition has positive read for Dyne Therapeutics, says Morgan Stanley

6d ago

DYN

Dyne Therapeutics up 37% after Avidity gets bought

PremiumThe Fly

6d ago

DYN

PremiumThe FlyAvidity Biosciences downgraded to Neutral from Buy at Roth Capital

6d ago

LLY

MRK

Avidity Biosciences downgraded to Hold from Buy at Needham

The Fly

Avidity Biosciences downgraded to Hold from Buy at Needham

6d ago

Avidity Biosciences downgraded to Market Perform from Strong Buy at Raymond James

The Fly

Avidity Biosciences downgraded to Market Perform from Strong Buy at Raymond James

6d ago

Novartis assumed with a Hold at Jefferies

PremiumThe Fly

6d ago

Cautious Hold Rating on Novartis AG Amid Mixed ianalumab Study Results and Uncertain Growth Prospects

PremiumRatings

6d ago

Novartis agrees to acquire Avidity for $72 per share in cash

PremiumThe Fly

6d ago

Novartis close to deal to buy Avidity for over $70 per share, Bloomberg says

PremiumThe Fly

7d ago

PremiumThe FlyCitizens JMP healthcare analysts hold an analyst/industry conference call

10d ago

BMY

Trump Trade: Trump administration prepares new probe into pharma prices

The Fly

Trump Trade: Trump administration prepares new probe into pharma prices

11d ago

AZN

Novartis announces expiration of HSR Act waiting period of Tourmaline Bio offer

The Fly

Novartis announces expiration of HSR Act waiting period of Tourmaline Bio offer

11d ago